Skip to content

Chronic Kidney Disease

A clinical study to evaluate the effect of Triphaladi Kashaya in the management of chronic kidney disease. - nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100956
Enrollment
50
Registered
2026-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N181- Chronic kidney disease, stage 1

Interventions

None listed

Sponsors

SriChandrasekharendraSaraswathiViswaMahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: subjects with symptoms of chronic Kidney diseases like oedema, pruritis, generalised weakness. high eGFR and serum creatinine and high BP

Exclusion criteria

Exclusion criteria: CKD subjects of stage 3, stage 4 and stage 5. subjects on dialysis therapy. subjects suffering from hepatitis/VDRL/HIV. uncontrolled DM. hypertension stage 2 and above pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
To improve the quality of life of CKD patients by reducing the occurrences of its complications and its associated hospitalizations.Timepoint: To improve the quality of life of CKD patients by reducing the occurrences of its complications and its associated hospitalizations.

Secondary

MeasureTime frame
To improve the metabolism & immunity of the patientsTimepoint: To improve the metabolism & immunity of the patients

Countries

India

Contacts

Public ContactDr Suvendu Rout

SRI JAYENDRA SARASWATI AYURVEDA COLLEGE & HOSPITAL

drsrout@gmail.com9444881980

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026